Akut mieloid leukémia (Hungarian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Akut mieloid leukémia" in Hungarian language version.

refsWebsite
Global rank Hungarian rank
4th place
11th place
2nd place
8th place
1st place
1st place
6th place
14th place
low place
low place
1,684th place
2,306th place
low place
low place
719th place
1,645th place
low place
low place
447th place
591st place
low place
6,582nd place

amcancersoc.org

caonline.amcancersoc.org

archive.org

ascopubs.org

jco.ascopubs.org

cancer.gov

seer.cancer.gov

cancer.gov

doi.org

dx.doi.org

  • Jemal A, Thomas A, Murray T, Thun M (2002). „Cancer statistics, 2002” (angol nyelven). CA Cancer J Clin 52 (1), 23–47. o. [2011. január 28-i dátummal az eredetiből archiválva]. DOI:10.3322/canjclin.52.1.23. PMID 11814064. (Hozzáférés: 2011. február 24.) 
  • Bennett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C (1976). „Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group” (angol nyelven). Br J Haematol 33 (4), 451–8. o. DOI:10.1111/j.1365-2141.1976.tb03563.x. PMID 188440. 
  • Vardiman JW, Harris NL, Brunning RD (2002). „The World Health Organization (WHO) classification of the myeloid neoplasms” (angol nyelven). Blood. 100 (7), 2292–302. o. [2009. december 17-i dátummal az eredetiből archiválva]. DOI:10.1182/blood-2002-04-1199. PMID 12239137. (Hozzáférés: 2011. február 20.) 
  • Vardiman JW, Thiele J, Arber DA, "et al." (2009. July). „The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.” (angol nyelven). Blood. 114 (5), 937-51.. o. DOI:10.1182/blood-2009-03-209262. PMID 19357394. 
  • Harris N, Jaffe E, Diebold J, Flandrin G, Muller-Hermelink H, Vardiman J, Lister T, Bloomfield C (1999). „The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997” (angol nyelven). Ann Oncol 10 (12), 1419–32. o. DOI:10.1023/A:1008375931236. PMID 10643532. 
  • Irons RD, Chen Y, Wang X, Ryder J, Kerzic PJ. (2013. October). „Acute myeloid leukemia following exposure to benzene more closely resembles de novo than therapy related-disease.” (angol nyelven). Genes Chromosomes Cancer. 52 (10), 887-94. o. DOI:10.1002/gcc.22084. PMID 23840003. 
  • Bizzozero O, Johnson K, Ciocco A (1966). „Radiation-related leukemia in Hiroshima and Nagasaki, 1946–1964. I. Distribution, incidence and appearance time” (angol nyelven). N Engl J Med 274 (20), 1095–101. o. DOI:10.1056/NEJM196605192742001. PMID 5932020. 
  • Evans D, Steward J (1972). „Down's syndrome and leukaemia” (angol nyelven). Lancet 2 (7790), 1322. o. DOI:10.1016/S0140-6736(72)92704-3. PMID 4117858. 
  • Sandler DP, Shore DL, Anderson JR, et al. (1993. December). „Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow.”. J Natl Cancer Inst. 85 (24), 1994-2003. o. DOI:10.1093/jnci/85.24.1994. PMID 8246285. 
  • Varadarajan R, Licht AS, Hyland AJ, et al. (2012. March). „Smoking adversely affects survival in acute myeloid leukemia patients.”. Int J Cancer. 130 (6), 1451-8. o. DOI:10.1002/ijc.26151. PMID 21520043. 
  • Shu XO, Ross JA, Pendergrass TW, et al. (1996. January). „Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study.”. J Natl Cancer Inst. 88 (1), 24-31. o. DOI:10.1093/jnci/88.1.24. PMID 8847721. 
  • Linggi B, Müller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW. (2002. July). „The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.” (angol nyelven). Nat Med. 8 (7), 743-50. o. DOI:10.1038/nm726. PMID 12091906. 
  • Sangle NA, Perkins SL. (2011. November). „Core-binding factor acute myeloid leukemia.” (angol nyelven). Arch Pathol Lab Med. 135 (11), 1504-9. o. DOI:10.5858/arpa.2010-0482-RS. PMID 22032582. 
  • Lo-Coco F, Avvisati G, et al. (2013. July). „Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.” (angol nyelven). N Engl J Med. 369 (2), 111-21. o. DOI:10.1056/NEJMoa1300874. PMID 23841729. 
  • Ley TJ, Mardis ER, Ding L, et al. (2008. November). „DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.” (angol nyelven). Nature. 456 (7218), 66-72. o. DOI:10.1038/nature07485. PMID 18987736. 
  • Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Löwenberg B, Bloomfield CD; European LeukemiaNet. (2010. January). „Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.” (angol nyelven). Blood. 115 (3), 453-74. o. DOI:10.1182/blood-2009-07-235358. PMID 19880497. 
  • Germing U, Strupp C, Kuendgen A, Aivado M, Giagounidis A, Hildebrandt B, Aul C, Haas R, Gattermann N. (2006. January). „Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.” (angol nyelven). Br J Haematol. 132 (2), 162-7. o. DOI:10.10.1111/j.1365-2141.2005.05853.x. PMID 16398650. 
  • Craig FE, Foon KA. (2008. April). „Flow cytometric immunophenotyping for hematologic neoplasms.” (angol nyelven). Blood. 111 (8), 3941-67. o. DOI:10.1182/blood-2007-11-1205358. PMID 18198345. 
  • Baldus CD, Mrózek K, Marcucci G, Bloomfield CD. (2007. June). „Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.” (angol nyelven). Br J Haematol. 137 (5), 387-400. o. DOI:10.1111/j.1365-2141.2007.06566.x. PMID 17488484. 
  • Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland CM, Serve H, Büchner T, Haferlach T, Hiddemann W. (2002. July). „Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.” (angol nyelven). Blood. 100 (1), 59-66. o. DOI:10.1182/blood.V100.1.59. PMID 12070009. 
  • Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland CM, Serve H, Büchner T, Haferlach T, Hiddemann W. (2005. November). „No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.” (angol nyelven). Blood. 106 (10), 3658-65. o. DOI:10.1182/blood-2005-03-1323. PMID 16076872. 
  • Koh Y, Park J, Ahn KS, Kim I, Bang SM, Lee JH, Yoon SS, Soon Lee D, Yiul Lee Y, Park S, Kim BK. (2009. November). „Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.” (angol nyelven). Ann Hematol. 88 (11), 1089-97. o. DOI:10.1007/s00277-009-0733-7. PMID 19296110. 
  • Ostronoff F, Estey E. (2013. September). „The role of quizartinib in the treatment of acute myeloid leukemia.” (angol nyelven). Expert Opin Investig Drugs.. DOI:110.1517/13543784.2013.842973. PMID 24070241. 
  • Paschka P, Marcucci G, Ruppert AS, Mrózek K, Chen H, Kittles RA, Vukosavljevic T, Perrotti D, Vardiman JW, Carroll AJ, Kolitz JE, Larson RA, Bloomfield CD; Cancer and Leukemia Group B. (2006. August). „Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.” (angol nyelven). J Clin Oncol. 24 (24), 3904-11. o. DOI:10.1200/JCO.2006.06.9500. PMID 16921041. 
  • Inoue D, Maruoka H, Takahashi T. (2010. August). „Clinical analysis and optimization of postremission therapy for acute myeloid leukemia patients with minimal residual disease as determined by flow cytometry.” (angol nyelven). Mediterr J Hematol Infect Dis. 2 (2), e2010020. o. DOI:10.4084/MJHID.2010.020. PMID 21415971. 
  • Mi JQ, Li JM, Shen ZX, Chen SJ, Chen Z. (2012. August). „How to manage acute promyelocytic leukemia.” (angol nyelven). Leukemia. 26 (8), 1743-51. o. DOI:10.1038/leu.2012.57. PMID 22422168. 
  • Lengfelder E, Hofmann WK, Nowak D. (2012. March). „Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia.” (angol nyelven). Leukemia. 26 (3), 433-42. o. DOI:10.1038/leu.2011.245. PMID 22422168. 
  • Wang ZY, Chen Z. (2008. March). „Acute promyelocytic leukemia: from highly fatal to highly curable.” (angol nyelven). Blood. 111 (5), 2505-15. o. DOI:10.1182/blood-2007-07-102798. PMID 18299451. 
  • Grimwade D, Mistry AR, Solomon E, Guidez F. (2010). „Acute promyelocytic leukemia: a paradigm for differentiation therapy.” (angol nyelven). Cancer Treat Res. 145, 219-35. o. DOI:10.1007/978-0-387-69259-3_13. PMID 20306254. 
  • Park JH, Qiao B, Panageas KS, Schymura MJ, Jurcic JG, Rosenblat TL, Altman JK, Douer D, Rowe JM, Tallman MS. (2011. August). „Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.” (angol nyelven). Blood. 118 (5), 1248-54. o. DOI:10.1182/blood-2011-04-346437. PMID 21653939. 
  • Park Kwaan HC, Cull EH. (2014. March). „The coagulopathy in acute promyelocytic leukaemia - What have we learned in the past twenty years.” (angol nyelven). Best Pract Res Clin Haematol. 27 (1), 11-18. o. DOI:10.1016/j.beha.2014.04.005. PMID 24907013. 
  • Yanada M, Matsuo K, Emi N, Naoe T. (2005. April). „Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis.” (angol nyelven). Cancer. 103 (8), 1652-8. o. DOI:10.1002/cncr.20945. PMID 15742336. 
  • Koreth J, Schlenk R, et al. (2009. June). „Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.” (angol nyelven). JAMA. 301 (22), 2349-61. o. DOI:10.1001/jama.2009.813. PMID 19509382. 
  • Shapira T, Pereg D, Lishner M. (2008. September). „How I treat acute and chronic leukemia in pregnancy.” (angol nyelven). Blood Rev. 22 (5), 247-59. o. DOI:10.1016/j.blre.2008.03.006. PMID 18472198. 
  • Cardonick E, Iacobucci A. (2004. May). „Use of chemotherapy during human pregnancy.” (angol nyelven). Lancet Oncol. 5 (5), 283-91. o. DOI:10.1016/S1470-2045(04)01466-4. PMID 15120665. 
  • Thol F, Schlenk RF. (2014. May). „Gemtuzumab ozogamicin in acute myeloid leukemia revisited.” (angol nyelven). Expert Opin Biol Ther., Ahead of print. o. DOI:10.1517/14712598.2014.922534. PMID 24865510. 
  • Creutzig U, van den Heuvel-Eibrink MM, Gibson B, et al. (2012. October). „Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.” (angol nyelven). Blood. 120 (16), 3187-205. o. DOI:10.1182/blood-2012-03-362608. PMID 22879540. 
  • Kaspers GJ. (2012. March). „Pediatric acute myeloid leukemia.” (angol nyelven). Expert Rev Anticancer Ther. 12 (3), 405-13. o. DOI:10.1586/era.12.1. PMID 16221060. 
  • Harrison CJ, Hills RK, Moorman AV, et al. (2010. June). „Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.” (angol nyelven). J Clin Oncol. 28 (16), 2674-81. o. DOI:10.1200/JCO.2009.24.8997. PMID 20439644. 
  • von Neuhoff C, Reinhardt D, Sander A, et al. (2010. June). „Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.” (angol nyelven). J Clin Oncol. 28 (16), 2682-9. o. DOI:10.1200/JCO.2009.25.6321. PMID 20439630. 
  • Pui CH, Howard SC. (2008. March). „Current management and challenges of malignant disease in the CNS in paediatric leukaemia.” (angol nyelven). Lancet Oncol. 9 (3), 257-68. o. DOI:10.1016/S1470-2045(08)70070-6. PMID 18308251. 

fda.gov

gyermekdaganat.hu

hematologylibrary.org

bloodjournal.hematologylibrary.org

medscape.com

emedicine.medscape.com

nih.gov

pubmed.ncbi.nlm.nih.gov

  • Jemal A, Thomas A, Murray T, Thun M (2002). „Cancer statistics, 2002” (angol nyelven). CA Cancer J Clin 52 (1), 23–47. o. [2011. január 28-i dátummal az eredetiből archiválva]. DOI:10.3322/canjclin.52.1.23. PMID 11814064. (Hozzáférés: 2011. február 24.) 
  • Jemal A, Siegel R, Ward E, Murray T, Xu J, Smigal C, Thun MJ. (2006). „Cancer statistics, 2006.” (angol nyelven). CA Cancer J Clin 56 (2), 106-130. o. PMID 16514137. 
  • Deschler B, Lübbert M. (2006. November). „Acute myeloid leukemia: epidemiology and etiology.” (angol nyelven). Cancer. 107 (9), 2099-107. o. PMID 17019734. 
  • Aquino VM. (2002. February). „Acute myelogenous leukemia.” (angol nyelven). Curr Probl Pediatr Adolesc Health Care. 32 (2), 50-8. o. PMID 11951090. 
  • Bennett J, Catovsky D, Daniel M, Flandrin G, Galton D, Gralnick H, Sultan C (1976). „Proposals for the classification of the acute leukaemias. French-American-British (FAB) co-operative group” (angol nyelven). Br J Haematol 33 (4), 451–8. o. DOI:10.1111/j.1365-2141.1976.tb03563.x. PMID 188440. 
  • Duchayne E, Demur C, Rubie H, Robert A, Dastugue N. (1999. January). „Diagnosis of acute basophilic leukemia.” (angol nyelven). Leuk Lymphoma. 32 (3-4), 269-78. o. PMID 10037024. 
  • Vardiman JW, Harris NL, Brunning RD (2002). „The World Health Organization (WHO) classification of the myeloid neoplasms” (angol nyelven). Blood. 100 (7), 2292–302. o. [2009. december 17-i dátummal az eredetiből archiválva]. DOI:10.1182/blood-2002-04-1199. PMID 12239137. (Hozzáférés: 2011. február 20.) 
  • Vardiman JW, Thiele J, Arber DA, "et al." (2009. July). „The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.” (angol nyelven). Blood. 114 (5), 937-51.. o. DOI:10.1182/blood-2009-03-209262. PMID 19357394. 
  • Sanz G, Sanz M, Vallespí T, Cañizo M, Torrabadella M, García S, Irriguible D, San Miguel J (1989). „Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients.” (angol nyelven). Blood 74 (1), 395–408. o. PMID 2752119. 
  • Harris N, Jaffe E, Diebold J, Flandrin G, Muller-Hermelink H, Vardiman J, Lister T, Bloomfield C (1999). „The World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. Report of the Clinical Advisory Committee meeting, Airlie House, Virginia, November, 1997” (angol nyelven). Ann Oncol 10 (12), 1419–32. o. DOI:10.1023/A:1008375931236. PMID 10643532. 
  • Le Beau M, Albain K, Larson R, Vardiman J, Davis E, Blough R, Golomb H, Rowley J (1986). „Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7” (angol nyelven). J Clin Oncol 4 (3), 325–45. o. PMID 3950675. 
  • Leone G, Mele L, Pulsoni A, Equitani F, Pagano L. (1986). „The incidence of secondary leukemias.” (angol nyelven). Haematologica. 84 (10), 937-56. o. PMID 10509043. 
  • Wong O. (1995. June). „Risk of acute myeloid leukaemia and multiple myeloma in workers exposed to benzene.” (angol nyelven). Occup Environ Med. 52 (6), 380-4. o. PMID 7627314. 
  • Irons RD, Chen Y, Wang X, Ryder J, Kerzic PJ. (2013. October). „Acute myeloid leukemia following exposure to benzene more closely resembles de novo than therapy related-disease.” (angol nyelven). Genes Chromosomes Cancer. 52 (10), 887-94. o. DOI:10.1002/gcc.22084. PMID 23840003. 
  • Bizzozero O, Johnson K, Ciocco A (1966). „Radiation-related leukemia in Hiroshima and Nagasaki, 1946–1964. I. Distribution, incidence and appearance time” (angol nyelven). N Engl J Med 274 (20), 1095–101. o. DOI:10.1056/NEJM196605192742001. PMID 5932020. 
  • Evans D, Steward J (1972). „Down's syndrome and leukaemia” (angol nyelven). Lancet 2 (7790), 1322. o. DOI:10.1016/S0140-6736(72)92704-3. PMID 4117858. 
  • Alter BP. (1996. October). „Fanconi's anemia and malignancies.”. Am J Hematol. 53 (2), 99-110. o. PMID 8892734. 
  • Horwitz M, Goode EL, Jarvik GP (1996). „Anticipation in familial leukemia” (angol nyelven). Am. J. Hum. Genet. 59 (5), 990–8. o. PMID 8900225. PMC 1914843. 
  • Gunz FW, Veale AM (1969). „Leukemia in close relatives--accident or predisposition?” (angol nyelven). J. Natl. Cancer Inst. 42 (3), 517–24. o. PMID 4180615. 
  • Severson RK. (1987. July). „Cigarette smoking and leukemia.”. Cancer. 60 (2), 141-4. o. PMID 3474051. 
  • Sandler DP, Shore DL, Anderson JR, et al. (1993. December). „Cigarette smoking and risk of acute leukemia: associations with morphology and cytogenetic abnormalities in bone marrow.”. J Natl Cancer Inst. 85 (24), 1994-2003. o. DOI:10.1093/jnci/85.24.1994. PMID 8246285. 
  • Varadarajan R, Licht AS, Hyland AJ, et al. (2012. March). „Smoking adversely affects survival in acute myeloid leukemia patients.”. Int J Cancer. 130 (6), 1451-8. o. DOI:10.1002/ijc.26151. PMID 21520043. 
  • Shu XO, Ross JA, Pendergrass TW, et al. (1996. January). „Parental alcohol consumption, cigarette smoking, and risk of infant leukemia: a Childrens Cancer Group study.”. J Natl Cancer Inst. 88 (1), 24-31. o. DOI:10.1093/jnci/88.1.24. PMID 8847721. 
  • Bonnet D, Dick JE. (1997. July). „Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell.” (angol nyelven). Nat Med. 3 (7), 730-7. o. PMID 9212098. 
  • Linggi B, Müller-Tidow C, van de Locht L, Hu M, Nip J, Serve H, Berdel WE, van der Reijden B, Quelle DE, Rowley JD, Cleveland J, Jansen JH, Pandolfi PP, Hiebert SW. (2002. July). „The t(8;21) fusion protein, AML1 ETO, specifically represses the transcription of the p14(ARF) tumor suppressor in acute myeloid leukemia.” (angol nyelven). Nat Med. 8 (7), 743-50. o. DOI:10.1038/nm726. PMID 12091906. 
  • Melnick A, Carlile GW, McConnell MJ, Polinger A, Hiebert SW, Licht JD. (2000. December). „AML-1/ETO fusion protein is a dominant negative inhibitor of transcriptional repression by the promyelocytic leukemia zinc finger protein.” (angol nyelven). Blood. 96 (12), 3939-47. o. PMID 11090081. [halott link]
  • Sangle NA, Perkins SL. (2011. November). „Core-binding factor acute myeloid leukemia.” (angol nyelven). Arch Pathol Lab Med. 135 (11), 1504-9. o. DOI:10.5858/arpa.2010-0482-RS. PMID 22032582. 
  • Lo-Coco F, Avvisati G, et al. (2013. July). „Retinoic acid and arsenic trioxide for acute promyelocytic leukemia.” (angol nyelven). N Engl J Med. 369 (2), 111-21. o. DOI:10.1056/NEJMoa1300874. PMID 23841729. 
  • Ley TJ, Mardis ER, Ding L, et al. (2008. November). „DNA sequencing of a cytogenetically normal acute myeloid leukaemia genome.” (angol nyelven). Nature. 456 (7218), 66-72. o. DOI:10.1038/nature07485. PMID 18987736. 
  • Dombret H, Scrobohaci ML, Ghorra P, Zini JM, Daniel MT, Castaigne S, Degos L. (1993. January). „Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.” (angol nyelven). Leukemia. 7 (1), 2-9. o. PMID 8418375. 
  • Döhner H, Estey EH, Amadori S, Appelbaum FR, Büchner T, Burnett AK, Dombret H, Fenaux P, Grimwade D, Larson RA, Lo-Coco F, Naoe T, Niederwieser D, Ossenkoppele GJ, Sanz MA, Sierra J, Tallman MS, Löwenberg B, Bloomfield CD; European LeukemiaNet. (2010. January). „Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet.” (angol nyelven). Blood. 115 (3), 453-74. o. DOI:10.1182/blood-2009-07-235358. PMID 19880497. 
  • Germing U, Strupp C, Kuendgen A, Aivado M, Giagounidis A, Hildebrandt B, Aul C, Haas R, Gattermann N. (2006. January). „Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals.” (angol nyelven). Br J Haematol. 132 (2), 162-7. o. DOI:10.10.1111/j.1365-2141.2005.05853.x. PMID 16398650. 
  • Craig FE, Foon KA. (2008. April). „Flow cytometric immunophenotyping for hematologic neoplasms.” (angol nyelven). Blood. 111 (8), 3941-67. o. DOI:10.1182/blood-2007-11-1205358. PMID 18198345. 
  • Slovak ML, Kopecky KJ, Cassileth PA, Harrington DH, Theil KS, Mohamed A, Paietta E, Willman CL, Head DR, Rowe JM, Forman SJ, Appelbaum FR (2000. December). „Karyotypic analysis predicts outcome of preremission and postremission therapy in adult acute myeloid leukemia: a Southwest Oncology Group/Eastern Cooperative Oncology Group Study.” (angol nyelven). Blood. 96 (13), 4075-83. o. PMID 11110676. [halott link]
  • Grimwade D, Walker H, Oliver F, Wheatley K, Harrison C, Harrison G, Rees J, Hann I, Stevens R, Burnett A, Goldstone A. (1998. October). „The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.” (angol nyelven). Blood. 92 (7), 2322-33. o. [2011. június 7-i dátummal az eredetiből archiválva]. PMID 9746770. (Hozzáférés: 2013. október 11.) 
  • Baldus CD, Mrózek K, Marcucci G, Bloomfield CD. (2007. June). „Clinical outcome of de novo acute myeloid leukaemia patients with normal cytogenetics is affected by molecular genetic alterations: a concise review.” (angol nyelven). Br J Haematol. 137 (5), 387-400. o. DOI:10.1111/j.1365-2141.2007.06566.x. PMID 17488484. 
  • Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland CM, Serve H, Büchner T, Haferlach T, Hiddemann W. (2002. July). „Analysis of FLT3 length mutations in 1003 patients with acute myeloid leukemia: correlation to cytogenetics, FAB subtype, and prognosis in the AMLCG study and usefulness as a marker for the detection of minimal residual disease.” (angol nyelven). Blood. 100 (1), 59-66. o. DOI:10.1182/blood.V100.1.59. PMID 12070009. 
  • Schnittger S, Schoch C, Dugas M, Kern W, Staib P, Wuchter C, Löffler H, Sauerland CM, Serve H, Büchner T, Haferlach T, Hiddemann W. (2005. November). „No evidence that FLT3 status should be considered as an indicator for transplantation in acute myeloid leukemia (AML): an analysis of 1135 patients, excluding acute promyelocytic leukemia, from the UK MRC AML10 and 12 trials.” (angol nyelven). Blood. 106 (10), 3658-65. o. DOI:10.1182/blood-2005-03-1323. PMID 16076872. 
  • Koh Y, Park J, Ahn KS, Kim I, Bang SM, Lee JH, Yoon SS, Soon Lee D, Yiul Lee Y, Park S, Kim BK. (2009. November). „Different clinical importance of FLT3 internal tandem duplications in AML according to FAB classification: possible existence of distinct leukemogenesis involving monocyte differentiation pathway.” (angol nyelven). Ann Hematol. 88 (11), 1089-97. o. DOI:10.1007/s00277-009-0733-7. PMID 19296110. 
  • Ostronoff F, Estey E. (2013. September). „The role of quizartinib in the treatment of acute myeloid leukemia.” (angol nyelven). Expert Opin Investig Drugs.. DOI:110.1517/13543784.2013.842973. PMID 24070241. 
  • Paschka P, Marcucci G, Ruppert AS, Mrózek K, Chen H, Kittles RA, Vukosavljevic T, Perrotti D, Vardiman JW, Carroll AJ, Kolitz JE, Larson RA, Bloomfield CD; Cancer and Leukemia Group B. (2006. August). „Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): a Cancer and Leukemia Group B Study.” (angol nyelven). J Clin Oncol. 24 (24), 3904-11. o. DOI:10.1200/JCO.2006.06.9500. PMID 16921041. 
  • Cassileth PA, Harrington DP, Hines JD, Oken MM, Mazza JJ, McGlave P, Bennett JM, O'Connell MJ. (1988. April). „Maintenance chemotherapy prolongs remission duration in adult acute nonlymphocytic leukemia.” (angol nyelven). J Clin Oncol. 6 (4), 583-7. o. PMID 3282032. 
  • Szczepański T, Orfão A, van der Velden VH, San Miguel JF, van Dongen JJ. (2001. July). „Minimal residual disease in leukaemia patients.” (angol nyelven). Lancet Oncol. 2 (7), 409-17. o. PMID 11905735. 
  • Inoue D, Maruoka H, Takahashi T. (2010. August). „Clinical analysis and optimization of postremission therapy for acute myeloid leukemia patients with minimal residual disease as determined by flow cytometry.” (angol nyelven). Mediterr J Hematol Infect Dis. 2 (2), e2010020. o. DOI:10.4084/MJHID.2010.020. PMID 21415971. 
  • Mi JQ, Li JM, Shen ZX, Chen SJ, Chen Z. (2012. August). „How to manage acute promyelocytic leukemia.” (angol nyelven). Leukemia. 26 (8), 1743-51. o. DOI:10.1038/leu.2012.57. PMID 22422168. 
  • Huang ME, Ye YC, Chen SR, Chai JR, Lu JX, Zhoa L, Gu LJ, Wang ZY. (1988. August). „Use of all-trans retinoic acid in the treatment of acute promyelocytic leukemia.” (angol nyelven). Blood. 72 (2), 567-72. o. PMID 3165295. [halott link]
  • Lengfelder E, Hofmann WK, Nowak D. (2012. March). „Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia.” (angol nyelven). Leukemia. 26 (3), 433-42. o. DOI:10.1038/leu.2011.245. PMID 22422168. 
  • Larson RS, Tallman MS. (2003. September). „Retinoic acid syndrome: manifestations, pathogenesis, and treatment.” (angol nyelven). Best Pract Res Clin Haematol. 16 (3), 453-61. o. PMID 12935962. 
  • Wang ZY, Chen Z. (2008. March). „Acute promyelocytic leukemia: from highly fatal to highly curable.” (angol nyelven). Blood. 111 (5), 2505-15. o. DOI:10.1182/blood-2007-07-102798. PMID 18299451. 
  • Grimwade D, Mistry AR, Solomon E, Guidez F. (2010). „Acute promyelocytic leukemia: a paradigm for differentiation therapy.” (angol nyelven). Cancer Treat Res. 145, 219-35. o. DOI:10.1007/978-0-387-69259-3_13. PMID 20306254. 
  • Park JH, Qiao B, Panageas KS, Schymura MJ, Jurcic JG, Rosenblat TL, Altman JK, Douer D, Rowe JM, Tallman MS. (2011. August). „Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid.” (angol nyelven). Blood. 118 (5), 1248-54. o. DOI:10.1182/blood-2011-04-346437. PMID 21653939. 
  • Park Kwaan HC, Cull EH. (2014. March). „The coagulopathy in acute promyelocytic leukaemia - What have we learned in the past twenty years.” (angol nyelven). Best Pract Res Clin Haematol. 27 (1), 11-18. o. DOI:10.1016/j.beha.2014.04.005. PMID 24907013. 
  • Bishop JF. (1997. February). „The treatment of adult acute myeloid leukemia.” (angol nyelven). Semin Oncol. 24 (1), 57-69. o. PMID 9045305. 
  • Elonen E, Almqvist A, et al. (1998. July). „Comparison between four and eight cycles of intensive chemotherapy in adult acute myeloid leukemia: a randomized trial of the Finnish Leukemia Group.” (angol nyelven). Leukemia. 12 (7), 1041-8. o. PMID 9665188. 
  • Yanada M, Matsuo K, Emi N, Naoe T. (2005. April). „Efficacy of allogeneic hematopoietic stem cell transplantation depends on cytogenetic risk for acute myeloid leukemia in first disease remission: a metaanalysis.” (angol nyelven). Cancer. 103 (8), 1652-8. o. DOI:10.1002/cncr.20945. PMID 15742336. 
  • Koreth J, Schlenk R, et al. (2009. June). „Allogeneic stem cell transplantation for acute myeloid leukemia in first complete remission: systematic review and meta-analysis of prospective clinical trials.” (angol nyelven). JAMA. 301 (22), 2349-61. o. DOI:10.1001/jama.2009.813. PMID 19509382. 
  • Vento S, Cainelli F. (2003. October). „Infections in patients with cancer undergoing chemotherapy: aetiology, prevention, and treatment.” (angol nyelven). Lancet Oncol. 4 (10), 595-604. o. PMID 14554236. 
  • Robenshtok E, Gafter-Gvili A, Goldberg E, Weinberger M, Yeshurun M, Leibovici L, Paul M. (2007. December). „Antifungal prophylaxis in cancer patients after chemotherapy or hematopoietic stem-cell transplantation: systematic review and meta-analysis.” (angol nyelven). J Clin Oncol. 25 (34), 5471-89. o. PMID 17909198. 
  • Gafter-Gvili A, Fraser A, Paul M, Leibovici L. (2005. June). „Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.” (angol nyelven). Ann Intern Med. 142 (12), 979-95. o. PMID 15968013. 
  • Estey EH. (2001. March). „Growth factors in acute myeloid leukaemia.” (angol nyelven). Best Pract Res Clin Haematol. 14 (1), 175-87. o. PMID 11355930. 
  • Moore JO, Dodge RK, Amrein PC, Kolitz J, Lee EJ, Powell B, Godfrey S, Robert F, Schiffer CA. (1997. February). „Granulocyte-colony stimulating factor (filgrastim) accelerates granulocyte recovery after intensive postremission chemotherapy for acute myeloid leukemia with aziridinyl benzoquinone and mitoxantrone: Cancer and Leukemia Group B study 9022.” (angol nyelven). Blood. 89 (3), 780-8. o. PMID 9028308. [halott link]
  • Schiffer CA, Anderson KC, et al. (2001. March). „Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology.” (angol nyelven). J Clin Oncol. 19 (5), 1519-38. o. PMID 11230498. [halott link]
  • Shapira T, Pereg D, Lishner M. (2008. September). „How I treat acute and chronic leukemia in pregnancy.” (angol nyelven). Blood Rev. 22 (5), 247-59. o. DOI:10.1016/j.blre.2008.03.006. PMID 18472198. 
  • Cardonick E, Iacobucci A. (2004. May). „Use of chemotherapy during human pregnancy.” (angol nyelven). Lancet Oncol. 5 (5), 283-91. o. DOI:10.1016/S1470-2045(04)01466-4. PMID 15120665. 
  • Sievers EL, Larson RA, Stadtmauer EA, et al. (2001. July). „Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse.” (angol nyelven). J Clin Oncol. 19 (13), 3244-54. o. PMID 11432892. 
  • Giles FJ, Kantarjian HM, Kornblau SM, et al. (2001. July). „Mylotarg (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation.” (angol nyelven). Cancer. 92 (2), 406-13. o. PMID 11466696. 
  • Thol F, Schlenk RF. (2014. May). „Gemtuzumab ozogamicin in acute myeloid leukemia revisited.” (angol nyelven). Expert Opin Biol Ther., Ahead of print. o. DOI:10.1517/14712598.2014.922534. PMID 24865510. 
  • Creutzig U, van den Heuvel-Eibrink MM, Gibson B, et al. (2012. October). „Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel.” (angol nyelven). Blood. 120 (16), 3187-205. o. DOI:10.1182/blood-2012-03-362608. PMID 22879540. 
  • Kaspers GJ. (2012. March). „Pediatric acute myeloid leukemia.” (angol nyelven). Expert Rev Anticancer Ther. 12 (3), 405-13. o. DOI:10.1586/era.12.1. PMID 16221060. 
  • Harrison CJ, Hills RK, Moorman AV, et al. (2010. June). „Cytogenetics of childhood acute myeloid leukemia: United Kingdom Medical Research Council Treatment trials AML 10 and 12.” (angol nyelven). J Clin Oncol. 28 (16), 2674-81. o. DOI:10.1200/JCO.2009.24.8997. PMID 20439644. 
  • von Neuhoff C, Reinhardt D, Sander A, et al. (2010. June). „Prognostic impact of specific chromosomal aberrations in a large group of pediatric patients with acute myeloid leukemia treated uniformly according to trial AML-BFM 98.” (angol nyelven). J Clin Oncol. 28 (16), 2682-9. o. DOI:10.1200/JCO.2009.25.6321. PMID 20439630. 
  • Dahl GV, Simone JV, Hustu HO, Mason C. (1978. November). „Preventive central nervous system irradiation in children with acute nonlymphocytic leukemia.” (angol nyelven). Cancer. 42 (5), 2187-92. o. PMID 102418. 
  • Pui CH, Howard SC. (2008. March). „Current management and challenges of malignant disease in the CNS in paediatric leukaemia.” (angol nyelven). Lancet Oncol. 9 (3), 257-68. o. DOI:10.1016/S1470-2045(08)70070-6. PMID 18308251. 

ncbi.nlm.nih.gov

web.archive.org